Legal & General Group
ACER

Legal & General Group’s Acer Therapeutics Inc ACER Stock Holding History

Legal & General Group’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,428
Closed -$3K – 3486
2020
Q1 		$3K Buy
1,428
+1,238
+652% +$4.54K ﹤0.01% 3318
2019
Q4 		$1K Buy
+190
New +$646 ﹤0.01% 3367

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group's ACER Position: Q2 2020 in Review

Legal & General Group sold out of Acer Therapeutics Inc (ACER) in Q2 2020, closing a stake of 1,428 shares — an estimated $3K sold.

Legal & General Group first reported a position in ACER in Q4 2019 and held it in 2 quarters. The position peaked at $3K in Q1 2020. 34 funds tracked by Wall St. Rank hold ACER as of Q2 2020.

  • Legal & General Group reported no remaining Acer Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Legal & General Group sold 1,428 Acer Therapeutics Inc shares in Q2 2020, an estimated $3K.
  • Legal & General Group first reported a position in Acer Therapeutics Inc in Q4 2019 and held it in 2 quarters.
  • Legal & General Group's Acer Therapeutics Inc position peaked at $3K in Q1 2020.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2020.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.